Log in

NYSEARCA:IXJiShares Global Healthcare ETF Stock Price, Forecast & News

$70.20
+0.68 (+0.98 %)
(As of 05/29/2020 04:00 PM ET)
Add
Today's Range
$68.99
Now: $70.20
$70.37
50-Day Range
$63.98
MA: $67.37
$69.52
52-Week Range
$51.07
Now: $70.20
$71.09
Volume84,388 shs
Average Volume205,178 shs
Market Capitalization$2.30 billion
P/E RatioN/A
Dividend Yield1.40%
BetaN/A
iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor's Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals. The Underlying Index consists of stocks of companies in countries, including Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Japan, the Netherlands, Switzerland, the United Kingdom and the United States. The Fund's investment advisor is BlackRock Fund Advisors (BFA).
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.83 out of 5 stars


Basic Details

Issuer iShares
Fund NameiShares Global Healthcare ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IXJ
Inception Date11/13/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone+1-800-4742737

Fund Focus

Asset ClassEquity
BenchmarkS&P Global 1200 Healthcare Sector Index
CategorySector
FocusHealth Care
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$2.30 billion
Average Daily Volume$207,468.40
Discount/Premium0.00%

ETF Expenses

Management Fee0.48%
Other Expenses0.00%
Total Expenses0.48%
Fee Waiver0.00%
Net Expenses0.48%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerIMC Chicago

Receive IXJ News and Ratings via Email

Sign-up to receive the latest news and ratings for IXJ and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of iShares Global Healthcare ETF (NYSEARCA:IXJ)
Currency Exposure of iShares Global Healthcare ETF (NYSEARCA:IXJ)
Sector Exposure of iShares Global Healthcare ETF (NYSEARCA:IXJ)
Industry Exposure of iShares Global Healthcare ETF (NYSEARCA:IXJ)

iShares Global Healthcare ETF (NYSEARCA:IXJ) Frequently Asked Questions

How has iShares Global Healthcare ETF's stock been impacted by COVID-19 (Coronavirus)?

iShares Global Healthcare ETF's stock was trading at $61.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IXJ stock has increased by 13.2% and is now trading at $70.20. View which stocks have been most impacted by Coronavirus.

How often does iShares Global Healthcare ETF pay dividends? What is the dividend yield for iShares Global Healthcare ETF?

iShares Global Healthcare ETF announced a semi-annual dividend on Monday, December 16th. Shareholders of record on Tuesday, December 17th will be paid a dividend of $0.4789 per share on Friday, December 20th. This represents a yield of 1.7%. The ex-dividend date of this dividend is Monday, December 16th. View iShares Global Healthcare ETF's dividend history.

When did iShares Global Healthcare ETF's stock split? How did iShares Global Healthcare ETF's stock split work?

iShares Global Healthcare ETF shares split before market open on Wednesday, May 2nd 2018. The 2-1 split was announced on Thursday, March 29th 2018. The newly minted shares were issued to shareholders after the market closes on Tuesday, May 1st 2018. An investor that had 100 shares of iShares Global Healthcare ETF stock prior to the split would have 200 shares after the split.

Has iShares Global Healthcare ETF been receiving favorable news coverage?

Headlines about IXJ stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Global Healthcare ETF earned a news impact score of 2.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutiShares Global Healthcare ETF.

What other stocks do shareholders of iShares Global Healthcare ETF own?

Who are iShares Global Healthcare ETF's key executives?

iShares Global Healthcare ETF's management team includes the following people:
  • Robert H. Silver, Independent Chairman of the Board of the Trustee (Age 58)
  • Michael Arthur Latham, President, Trustee (Age 51)
  • Jack Gee, Chief Financial Officer, Treasurer (Age 57)
  • Scott F. Radell, Executive Vice President (Age 48)
  • Amy Schioldager, Executive Vice President (Age 56)
  • Edward B. Baer, Vice President, Chief Legal Officer (Age 45)
  • Ira P. Shapiro, Vice President (Age 52)
  • Eilleen M. Clavere, Secretary (Age 61)
  • Cecilia H. Herbert, Independent Trustee (Age 68)
  • Charles A. Hurty, Independent Trustee (Age 73)

What is iShares Global Healthcare ETF's stock symbol?

iShares Global Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IXJ."

Who are iShares Global Healthcare ETF's major shareholders?

iShares Global Healthcare ETF's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (32.32%), Richard Bernstein Advisors LLC (2.45%), Morgan Stanley (1.80%), Morgan Stanley (1.78%), Bank of New York Mellon Corp (1.16%) and Morningstar Investment Services LLC (1.11%).

Which institutional investors are selling iShares Global Healthcare ETF stock?

IXJ stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Jane Street Group LLC, Cambridge Investment Research Advisors Inc., Alliancebernstein L.P., UBS Group AG, Exencial Wealth Advisors LLC, Commonwealth Equity Services LLC, and Mandatum Life Insurance Co Ltd.

Which institutional investors are buying iShares Global Healthcare ETF stock?

IXJ stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Bank of New York Mellon Corp, Advisor Group Holdings Inc., FDx Advisors Inc., FDx Advisors Inc., Richard Bernstein Advisors LLC, and Fisher Asset Management LLC.

How do I buy shares of iShares Global Healthcare ETF?

Shares of IXJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares Global Healthcare ETF's stock price today?

One share of IXJ stock can currently be purchased for approximately $70.20.

How big of a company is iShares Global Healthcare ETF?

iShares Global Healthcare ETF has a market capitalization of $2.30 billion.

What is iShares Global Healthcare ETF's official website?

The official website for iShares Global Healthcare ETF is us.ishares.com.

How can I contact iShares Global Healthcare ETF?

iShares Global Healthcare ETF's mailing address is 45 Fremont Street, San Fransisco, 94105, United States. The company can be reached via phone at +1-800-4742737.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.